NDC product
NP Thyroid 30
NDC 42192-329 · Acella Pharmaceuticals, LLC
Key facts
| Product NDC | 42192-329 |
|---|---|
| Proprietary name | NP Thyroid 30 |
| Nonproprietary name | LEVOTHYROXINE, LIOTHYRONINE |
| Substances | LEVOTHYROXINE, LIOTHYRONINE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Acella Pharmaceuticals, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Thyroxine [CS], Triiodothyronine [CS], l-Thyroxine [EPC], l-Triiodothyronine [EPC] |
| Marketing start | Jan 14, 2011 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: